Letter by Reynolds et al regarding article, "risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation

An analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial"

Stephanie Reynolds, David Parra, Robert S. Rosenstein

Research output: Contribution to journal › Article

1 Citation (Scopus)
Original languageEnglish
JournalCirculation
Volume125
Issue number3
DOIs
StatePublished - Jan 24 2012

Fingerprint

Benzimidazoles
beta-Alanine
Warfarin
Anticoagulants
Atrial Fibrillation
Hemorrhage
Therapeutics
Dabigatran

ASJC Scopus subject areas

  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

Letter by Reynolds et al regarding article, "risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation : An analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial". / Reynolds, Stephanie; Parra, David; Rosenstein, Robert S.

In: Circulation, Vol. 125, No. 3, 24.01.2012.

Research output: Contribution to journal › Article

Reynolds, S, Parra, D & Rosenstein, RS 2012, 'Letter by Reynolds et al regarding article, "risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: An analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial"', Circulation, vol. 125, no. 3. https://doi.org/10.1161/CIRCULATIONAHA.111.056077
Reynolds S, Parra D, Rosenstein RS. Letter by Reynolds et al regarding article, "risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: An analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial". Circulation. 2012 Jan 24;125(3). https://doi.org/10.1161/CIRCULATIONAHA.111.056077
Reynolds, Stephanie ; Parra, David ; Rosenstein, Robert S. / Letter by Reynolds et al regarding article, "risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation : An analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial". In: Circulation. 2012 ; Vol. 125, No. 3.
@article{b134c241ff6f43288b710ca5816979a8,
title = "Letter by Reynolds et al regarding article, {"}risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: An analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial{"}",
author = "Stephanie Reynolds and David Parra and Rosenstein, {Robert S.}",
year = "2012",
month = "1",
day = "24",
doi = "10.1161/CIRCULATIONAHA.111.056077",
language = "English",
volume = "125",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Letter by Reynolds et al regarding article, "risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation

T2 - An analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial"

AU - Reynolds, Stephanie

AU - Parra, David

AU - Rosenstein, Robert S.

PY - 2012/1/24

Y1 - 2012/1/24

UR - http://www.scopus.com/inward/record.url?scp=84856425969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856425969&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.111.056077

DO - 10.1161/CIRCULATIONAHA.111.056077

M3 - Article

VL - 125

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 3

ER -

Access to Document